101 related articles for article (PubMed ID: 2139910)
1. [Immunological effects of captopril and ramipril in patients with hypertension].
Vil'chinskaia MIu; Nasonov EL; Zharova EA; Panfilov VV; Masenko VP; Oshchepkova EV; Beliakova EV
Klin Med (Mosk); 1990 Feb; 68(2):61-4. PubMed ID: 2139910
[TBL] [Abstract][Full Text] [Related]
2. Comparative double-blind study of ramipril and captopril in mild to moderate essential hypertension.
Witte PU; Walter U
Am J Cardiol; 1987 Apr; 59(10):115D-120D. PubMed ID: 3034018
[TBL] [Abstract][Full Text] [Related]
3. Disappearance of captopril-induced taste disturbance after substitution with angiotensin-converting-enzyme inhibitor HOE 498.
Mauersberger H; Witte PU
Lancet; 1985 Mar; 1(8427):517-8. PubMed ID: 2857878
[No Abstract] [Full Text] [Related]
4. Acute hemodynamic and hormonal effects of ramipril in chronic congestive heart failure and comparison with captopril.
de Graeff PA; Kingma JH; Dunselman PH; Wesseling H; Lie KI
Am J Cardiol; 1987 Apr; 59(10):164D-170D. PubMed ID: 3034026
[TBL] [Abstract][Full Text] [Related]
5. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
Vasmant D; Bender N
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
[TBL] [Abstract][Full Text] [Related]
6. Ramipril and captopril in patients with heart failure: effects on hemodynamics and vasoconstrictor systems.
Manthey J; Osterziel KJ; Röhrig N; Dietz R; Hackenthal E; Schmidt-Gayk H; Kübler W
Am J Cardiol; 1987 Apr; 59(10):171D-175D. PubMed ID: 2953224
[TBL] [Abstract][Full Text] [Related]
7. Humoral and blood pressure effects of the angiotensin converting enzyme inhibitor ramipril in essential hypertension.
Lenz T; Distler A; Haller H; Meyer-Sabellek W; Wilp C; Tansey MJ; Eckert HG; Metzger H; Irmisch R; Philipp T
Arzneimittelforschung; 1986 Nov; 36(11):1693-6. PubMed ID: 3028438
[TBL] [Abstract][Full Text] [Related]
8. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.
Bauer B; Lorenz H; Zahlten R
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S70-4. PubMed ID: 2474109
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of severe essential hypertension with the new angiotensin converting enzyme inhibitor ramipril.
Predel HG; Düsing R; Bäcker A; Kipnowski J; Kramer HJ
Am J Cardiol; 1987 Apr; 59(10):143D-148D. PubMed ID: 3034023
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
Moursi MG; Ganten D; Lang RE; Unger T
J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
[TBL] [Abstract][Full Text] [Related]
11. Effect of ramipril, a new angiotensin converting enzyme inhibitor, on diurnal variations of blood pressure in essential hypertension.
Kaneko Y; Omae T; Yoshinaga K; Iimura O; Inagaki Y; Ishii M; Saruta T; Yamada K; Kumahara Y; Ito K
Am J Cardiol; 1987 Apr; 59(10):86D-91D. PubMed ID: 3034040
[TBL] [Abstract][Full Text] [Related]
12. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of ramipril treatment in hypertensive subjects with non-insulin-dependent diabetes mellitus.
Janka HU; Nuber A; Mehnert H
Arzneimittelforschung; 1990 Apr; 40(4):432-5. PubMed ID: 2141472
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension.
Karlberg BE; Lindström T; Rosenqvist U; Ohman KP
Am J Cardiol; 1987 Apr; 59(10):104D-109D. PubMed ID: 3034016
[TBL] [Abstract][Full Text] [Related]
15. Ramipril: a review of the new ACE inhibitor.
Mills TP
J Ark Med Soc; 1992 Feb; 88(9):437-40. PubMed ID: 1532570
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important.
Wenting GJ; Blankestijn PJ; Poldermans D; van Geelen J; Derkx FH; Man in't Veld AJ; Schalekamp MA
Am J Cardiol; 1987 Apr; 59(10):92D-97D. PubMed ID: 3034041
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic effects of ramipril and captopril in congestive heart failure.
de Graeff PA; Kingma JH; Viersma JW; Wesseling H; Lie KI
Int J Cardiol; 1989 Apr; 23(1):59-67. PubMed ID: 2523870
[TBL] [Abstract][Full Text] [Related]
18. [Ambulatory multicenter study of Triatec (ramipril). Observations concerning the lessons of the trial for the realization of future trials and for the management of hypertensive patients].
Battaglia C; Gallet M; Carré A
Rev Prat; 1990 Jun; 40(18 Suppl):45-7. PubMed ID: 2143598
[No Abstract] [Full Text] [Related]
19. A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo.
Villamil AS; Cairns V; Witte PU; Bertolasi CA
Am J Cardiol; 1987 Apr; 59(10):110D-114D. PubMed ID: 3034017
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the efficacy, tolerance, and safety of ramipril in diabetic patients with mild-to-moderate hypertension: a retrospective analysis.
Erhard W; Lindner U; Krall H; Breitstadt A; Pfeiffer C
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S160-4. PubMed ID: 1725032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]